June 2026

• Bacteriophages in Acne Reveal Novel Mechanism
• Mineral Sunscreens Across Diverse Skin Tones
• Botulinum Toxin for Acne and Scarring
• Long-Term Skin Health in Acne
• Patient Perspectives on Rosacea Forum Reddit
• Dual Therapy for Treatment-Resistant Atopic Dermatitis

June 2026 Supplement

Emerging Topical Approaches in the Management of Female Pattern Hair Loss

May 2026

Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma

Pembrolizumab Therapy in Stage III and IV Melanoma

Malassezia Folliculitis: Presentation, Diagnosis, Treatment

Topical Metformin vs Kligman Formula in Melasma

Metformin in Skin Cancer: Mechanistic and Clinical Insights

Weight Loss and Its Impact on Soft Tissue

May 2026 Supplement 1

Mechanism Matters: Il-17  Receptor Blockade with Brodalumab and Its Role in Durable Psoriasis Clearance  and Fast Onset of Action

April 2026

SPECIAL TOPIC: IMMUNODERMATOLOGY

• Remibrutinib Mechanism of Action Dermatologic Conditions
• Racial and Ethnic Representation Janus Kinase Inhibitors
• Isotretinoin Risk Inflammatory Bowel Disease TriNetX
• Eruptive Lentiginosis Within Resolved Psoriasis Plaques
• Diagnostic Accuracy and Pitfalls of Artificial Intelligence Models
• Treatment of Dystrophic Epidermolysis Bullosa With Abrocitinib

April 2026 Supplement 1

Real-World Cases of a Novel Topical Tranexamic Acid Aerum in Treatment of Hyperpigmentation

April 2026 Supplement 2

2025 Poster Abstracts Supplement

March 2026

• Brodalumab’s 8-Year Efficacy and Safety
• Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis
• Efficacy and Safety of Janus Kinase Inhibitors
• Updates on Therapeutic Approaches for Androgenetic Alopecia
• Reversal of Alopecia Totalis Utilizing Dupilumab
• Hair Prosthetic Injuries in Emergency Department Cases
• Topical Ruxolitinib Therapy and Depression Rates

February 2026 Supplement 1

PRE-, INTRA-, AND POSTPROCEDURE SKINCARE

February 2026

• Practical Algorithm for Acne Treatment
• Efficacy and Safety of Clascoterone Cream
• ChatGPT and DeepSeek in Dermatologic Practice
• Efficacy Treatment of Periorbital Hyperpigmentation
• GLP-1 Agonists in Hidradenitis Suppurativa
• Reddit Discourse on Eczema Misinformation

February 2026 Supplement 1

A NOVEL ORAL TREATMENT FOR PSORIASIS: DEUCRAVACITINIB

January 2026

• Cutaneous Adverse Events With GLP-1 Agonists
• Regulatory Landscape of Regenerative Dermatology Frameworks
• Malassezin Compared With Hydroquinone for Melasma
• Novel Topical Agent for Hyperpigmentation Management
• Advanced Multimodal Skin Tone Correcting Serum
• Thiamidol Regimen Compared With SPF Alone

January 2026 Supplement 1

Advancing Care for Thinning Skin: Clinical Evidence and Scientific Insights in Dermatoporosis

December 2025

• Pyoderma Gangrenosum Following Total Colectomy
• Report From the IDEOM Annual Meeting
• GLP-1 Receptor Agonists in HS
• Tirzepatide for Moderate to Severe Hidradenitis Suppurativa
• Atherosclerotic Cardiovascular Disease in Inflammatory Skin Disease
• Clinical Evaluation of Thiamidol Formulations for Hyperpigmentation

December 2025 Supplement

Nordic European Cutaneous Oncodermatology Management (Necom) 7: Real-World Cases Applying Recommendations for the Prevention and Treatment of Skin Reactions Related  to Cancer Therapies Using Skin-Protective Measures